MoneyWorks4Me

Beryl Drugs - Quaterly Results

08 Feb 2025 Evaluate
The sales declined to Rs. 54.02 millions for the December 2024 quarter as compared to Rs. 76.61 millions during the corresponding quarter last year.Net profit was down at Rs. 0.52  millions against Rs. 3.10 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -83.23%.The company reported a degrowth in operating Profit to 5.93 millions from 7.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 54.02 76.61 -29.49 173.34 239.17 -27.52 271.25 271.40 -0.06
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 5.93 7.96 -25.50 21.43 26.49 -19.10 26.74 22.35 19.64
Interest 1.20 1.13 6.19 4.51 3.30 36.67 4.64 4.36 6.42
PBDT 4.73 6.83 -30.75 16.92 23.19 -27.04 22.10 17.99 22.85
Depreciation 3.13 3.08 1.62 9.30 8.85 5.08 12.01 8.14 47.54
PBT 1.60 3.75 -57.33 7.62 14.34 -46.86 10.09 9.85 2.44
TAX 1.08 0.65 66.15 3.37 3.17 6.31 2.41 2.18 10.55
Deferred Tax 0.34 -0.46 -173.91 0.00 -1.94 -100.00 -1.98 0.58 -441.38
PAT 0.52 3.10 -83.23 4.25 11.17 -61.95 7.68 7.67 0.13
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 10.98 10.39 5.65 12.36 11.08 11.62 9.86 8.24 19.71
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1212.30
Cipla 1368.65
Lupin 2121.05
Zydus Lifesciences 1170.00
View more..